Benjamin J. Hindson 10x Genomics, Inc. (TXG) insider trading activity

TXG Quotes by TradingView

Benjamin J. Hindson is of 10x Genomics, Inc.. Currently has a direct ownership of 440,888 shares of TXG, which is worth approximately $5.43 Million. The most recent transaction as insider was on Mar 19, 2021, when has been sold 11,169 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 441K
1.67% 3M change
27.53% 12M change
Total Value Held $5.43 Million

Benjamin J. Hindson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2021
BUY
Grant, award, or other acquisition
-
11,169 Added 18.94%
47,805 Class A Common Stock
Mar 12 2021
SELL
Open market or private sale
$6,541,978 $157.01 p/Share
41,666 Reduced 53.21%
36,636 Class A Common Stock
Mar 12 2021
BUY
Exercise of conversion of derivative security
$40,833 $0.98 p/Share
41,666 Added 34.73%
78,302 Class A Common Stock
Feb 01 2021
SELL
Open market or private sale
$5,949,787 $176.29 p/Share
33,750 Reduced 47.95%
36,636 Class A Common Stock
Jan 04 2021
SELL
Open market or private sale
$4,731,750 $140.2 p/Share
33,750 Reduced 32.41%
70,386 Class A Common Stock
Dec 24 2020
BUY
Exercise of conversion of derivative security
$38,101 $1.04 p/Share
36,636 Added 26.03%
104,136 Class A Common Stock
Dec 01 2020
SELL
Open market or private sale
$5,127,637 $151.93 p/Share
33,750 Reduced 33.33%
67,500 Class A Common Stock
Dec 01 2020
BUY
Exercise of conversion of derivative security
$29,700 $0.88 p/Share
33,750 Added 25.0%
101,250 Class A Common Stock
Nov 03 2020
SELL
Open market or private sale
$1,738,890 $137.05 p/Share
12,688 Reduced 15.82%
67,500 Class A Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
$11,165 $0.88 p/Share
12,688 Added 13.66%
80,188 Class A Common Stock
Nov 02 2020
SELL
Open market or private sale
$2,888,232 $137.13 p/Share
21,062 Reduced 23.78%
67,500 Class A Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$18,535 $0.88 p/Share
21,062 Added 19.21%
88,562 Class A Common Stock
Oct 01 2020
SELL
Open market or private sale
$4,240,688 $125.65 p/Share
33,750 Reduced 33.33%
67,500 Class A Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$29,700 $0.88 p/Share
33,750 Added 25.0%
101,250 Class A Common Stock
BJH

Benjamin J. Hindson

Pleasanton, CA

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TXG